Skip to content
Screener

ADMA Biologics ADMA ADMA Bio Manufacturing — Research And Development Expense

Other segment segments

Plasma Collection Centers
$0—

Similar metrics at other companies

Amplitech Group, Inc. logo
AMPGManufacturing And Engineering — Research And Development Expense
$503.05K-32.0%
MapLight Therapeutics, Inc. logo
MPLTChemistry Manufacturing And Controls Expenses — Research And Development Expense
$6.42M+62.2%
OSI Systems logo
OSISOptoelectronics And Manufacturing Division — Research And Development Expense
$1.28M+0.9%
Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Solid Biosciences Inc. logo
SLDBInternal Research And Development Expense — Research And Development Expense
$9.06M+33.9%
Disc Medicine logo
IRONInternal Research And Development — Research And Development Expense
$11.31M+67.6%

Other financials

Income statement

See full
Revenue$124.4M+2.0%
Gross profit$86.3M+28.3%
Operating income$52.4M+22.5%
Net income$37.8M+10.5%
EPS (diluted)$0.16+14.3%

Balance sheet

See full
Cash & equivalents$136.0M+50.7%
Total debt$203.9M+1,855%
Total equity$408.2M+2.5%
Total assets$684.2M+22.5%

Cash flow

See full
Operating cash flow$29.5M+39.7%
CapEx$2.3M-6.9%
Free cash flow$27.3M+45.8%

Valuation

See full
Market cap$2.25B-49.1%
Enterprise value$2.32B-46.6%
P/E13.3×-7.9×
P/S4.4×-4.9×

Profitability

See full
Gross margin64.7%+11.7pp
Operating margin43.8%+11.0pp
Net margin33%-11.1pp
FCF margin22.7%+8.9pp

Returns & leverage

See full
Return on equity41.9%-29.3pp
Debt / equity0.5×+0.5×
Current ratio7×+1.6×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001140361-26-031445
(in thousands)ADMA Bio ManufacturingPlasma Collection CentersTotal
Revenues$$123,637$723124,360
Cost of product revenue37,56455438,118
Research and development6,014-6,014
Plasma center operating expenses-1,0261,026
Gain on sale of plasma centers---
Selling, marketing and distribution7,634-7,634
Depreciation and amortization expense1,2814991,780
General and administrative expense8,340-8,340

Item 1. Financial Statements.

FAQ

What is ADMA Biologics's ADMA bio manufacturing — research and development expense?
ADMA Biologics (ADMA) reported ADMA bio manufacturing — research and development expense of $6.01M in Q2 2026.
How has ADMA Biologics's ADMA bio manufacturing — research and development expense changed year-over-year?
ADMA Biologics's ADMA bio manufacturing — research and development expense increased by 483.3% year-over-year, from $1.03M to $6.01M.
What is the long-term trend for ADMA Biologics's ADMA bio manufacturing — research and development expense?
Over 3 years (2022 to 2025), ADMA Biologics's ADMA bio manufacturing — research and development expense has grown at a 9.6% compound annual growth rate (CAGR), from $3.61M to $4.76M.
What does ADMA bio manufacturing — research and development expense mean?
Captures the costs associated with the discovery, development, and clinical testing of new specialty biologics within the manufacturing segment. This investment reflects the company's commitment to long-term innovation and future product pipeline expansion.

Ask your AI about ADMA Biologics's adma bio manufacturing — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude